Drug/Diagnostic R&D Guidance Will Accommodate Biomarker Data Diversity
A retrospective study approach to drug and diagnostic co-development may be appropriate to verify a test's clinical utility in certain cases, FDA notes in a draft concept paper
A retrospective study approach to drug and diagnostic co-development may be appropriate to verify a test's clinical utility in certain cases, FDA notes in a draft concept paper